51ÔÚÏß

This collaboration will enable the expansion of expert services offerings in support of drug substance and drug product development.

WEST LAFAYETTE, Ind., Oct. 3, 2024 /PRNewswire-PRWeb/ -- Improved Pharma, a leading research and development consulting services company, today announced a strategic collaboration with Videra Advisors, LLC. This partnership will expand the company's expert services offerings to the pharmaceutical industry, providing enhanced support for drug substance and drug product development.

Dr. David A. Engers, founder and President of Videra Advisors, will join Improved Pharma as a consultant. Dr. Engers brings a wealth of industry technical experience in pharmaceutical science, with a particular focus on and development strategies, and materials characterization. His expertise in will be instrumental in addressing complex challenges related to drug solubility, bioavailability, and stability. Dr. Engers has a proven track record in developing innovative strategies to improve the oral bioavailability of poorly water-soluble compounds, including the use of and advanced formulation techniques. His work has helped advance both early and late stage programs, including the successful risk assessments and technology transfers of product and processes for high-potency formulations. Dr. Engers has presented and published on a range of topics, including lectures at the United States Patent and Trademark Office and the Canadian Intellectual Property Office. Dr. Engers currently serves as an adjunct professor in the Department of Industrial and Molecular Pharmaceutics at Purdue University.

"I am excited to collaborate with the talented Improved Pharma team," states Dr. Engers "Improved Pharma embodies the innovative spirit of its founders that has decades of world class problem solving successes in stability, solid forms, crystallization, polymorphism, formulation and particle engineering. This foundation is essential to innovations in new areas, such as developing novel crystallization technologies in and hypergravity for growing the space economy, the emerging area of co-processed materials, and pharmaceutical materials characterization using synchrotron light sources and vibrational microspectroscopy techniques. I'm happy to offer my expertise as Improved Pharma continues to advance these important technical areas." Dr. Pamela Smith, COO of Improved Pharma added, "Dr. Engers's deep knowledge and experience will be invaluable as we continue to grow and expand our services. This partnership will allow us to offer our clients even more comprehensive and effective solutions to meet their pharmaceutical development needs."

Both Videra Advisors and Improved Pharma are located at the Purdue Research Park, West Lafayette, IN.

Videra Advisors, LLC is an independent consulting firm that brings development expertise to pre-clinical and clinical stage pharmaceutical and biopharmaceutical companies. Leveraging over 25 years working for sponsor and contract services companies, extensive experience in operations leadership, strategy and enterprise risk management, technical diligence, quality leadership maturity, and scientific-based design of pharmaceutical dosage forms intended for preclinical, clinical development, and commercialization. The company was founded in 2024.

Improved Pharma is a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.

Media Contact

Pam Smith, Improved Pharma, (765) 463-9951, [email protected],  

SOURCE Improved Pharma